 |







 |
Changes in
hormones such as estrogen may trigger symptoms in patients with CPT II deficiency, suggests Stephen Zierz, M.D.
“Numerous studies have established that total CPT activity and its kinetics are regulated by glucagon, insulin, and estrogen,” says Zierz, Professor of Neurology at the University of Halle-Wittenberg. Thus in patients with impaired regulation of CPT II, hormonal effects or changes have the potential to trigger symptoms.
Zierz also notes that total CPT activity is significantly altered by fasting, diabetes, and hypothyroidism and is influenced by
phospholipids.
Effect
of ovarian hormones on mitochondrial enzyme activity in the fat
oxidation pathway of skeletal muscle. Campbell
SE et al. Am J Physiol Endocrinol Metab
2001;281(4):E803-8
Regulation
of liver carnitine palmitoyltransferase I gene expression by
hormones and fatty acids. Louet
JF et al. Biochem Soc Trans 2001 29(pt2):310-6
Estradiol
may limit lipid oxidation via CPT I expression and hormonal
mechanisms. Gower
BA et al. Obes Res 2002 10(3):167-72 |
|